The existing state-of-the-art recognizes nutrition as a fundamental aspect of life, intricately linked to various components, systems, and processes, particularly during disease states such as infections. The relationship between nutrition and infection is well-documented, highlighting how malnutrition can increase susceptibility to infections and the significant burden posed by foodborne illnesses.

Foodborne diseases result from the ingestion of contaminated food products and encompass a wide range of illnesses caused by various pathogens. The most severe cases often occur in the elderly, young children, individuals with compromised immune systems, and healthy individuals exposed to high doses of pathogenic organisms. The ingestion of pathogens in quantities sufficient to cause symptomatic infections can adversely affect the body, disrupting immune system equilibrium.

The role of nutrition in such conditions is critical for restoring balance to an immune system overwhelmed by pathogens. The environmental factors, including the microbiome and dysbiosis, play a significant role in the pathogenesis of non-communicable diseases (NCDs) and certain cancers. Therapeutic immunomodulatory nutraceutical interventions are proposed as a means to manage these diseases.

In another embodiment, the DINI Axis highlights the potential of dietary modifications alone to reduce the incidence of non-communicable diseases such as diabetes, stroke, and certain cancers.

“This approach opens new avenues for disease prevention and management through targeted nutritional strategies”. Based on the DINI Axis, we are advancing a diverse range of products tailored for various NCDs (such as cardiovascular diseases, diabetes, stroke, PCOD, osteoporosis, non-alcoholic fatty liver disease (NAFLD), autoimmune diseases, etc.) and cancers (including CRC, cervical cancer, breast cancer, etc.).
Our formulation development processes are specifically geared towards addressing CRC and other related conditions.